4-({[(pyridin-3-yl)methyl]amino}methylidene)-4,5-dihydro-1H-pyrazol-5-one

Catalog No. :
ACBXGX213
CAS No. :
338975-74-9
Molecular Formula :
C10H10N4O
Molecular Weight :
202.22

IUPAC Name:(Z)-4-(((pyridin-3-ylmethyl)amino)methylene)-2,4-dihydro-3H-pyrazol-3-one

4-({[(pyridin-3-yl)methyl]amino}methylidene)-4,5-dihydro-1H-pyrazol-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg90%$81.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-({[(pyridin-3-yl)methyl]amino}methylidene)-4,5-dihydro-1H-pyrazol-5-one
IUPAC Name(Z)-4-(((pyridin-3-ylmethyl)amino)methylene)-2,4-dihydro-3H-pyrazol-3-one
MDL No.MFCD00127675
Molecular FormulaC10H10N4O
Molecular Weight202.22
SMILESO=C1NN=C/C1=C/NCC1=CC=CN=C1
InChI KeyISVHKHNDQGZVKQ-TWGQIWQCSA-N
Synonym4-([(3-PYRIDINYLMETHYL)AMINO]METHYLENE)-2,4-DIHYDRO-3H-PYRAZOL-3-ONE;4-({[(pyridin-3-yl)methyl]amino}methylidene)-4,5-dihydro-1H-pyrazol-5-one;3H-Pyrazol-3-one, 2,4-dihydro-4-[[(3-pyridinylmethyl)amino]methylene]-
CAS No.338975-74-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBXGX213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBXGX213 route product structure diagram
    ACBXGX213338975-74-9
Inquiry

2. ACBXGX213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBXGX213 route product structure diagram
    ACBXGX213338975-74-9
Inquiry

Comments (0)